Oncolytic Virus Therapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
13
NCT05057715
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
Phase: Phase 1
Role: Collaborator
Start: Mar 2, 2022
Completion: Sep 30, 2038
Loading map...